Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs
JAMA Health Forum
Authors
Jalpa A Doshi, Pengxiang Li, Matthew J Klebanoff, John K Lin
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
Unfairness toward rural beneficiaries in Medicare's hierarchical conditions categories score
Health Affairs ScholarSeptember 23, 2025 -
Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis
Neurology Clinical PracticeSeptember 16, 2025 -
Physician and Hospital Performance in Medicare’s Updated Bundled-Payment Model for Joint Replacement
JAMA Health ForumJuly 25, 2025 -
A Physician and Practice Incentive Intervention to Increase Referrals to High-Value Settings
NEJM CatalystJuly 16, 2025 -
Behaviourally-Informed Two-Way Text Messaging to Improve Return to HIV Care in South Africa: Evidence from a Randomised Controlled Trial
AIDS and BehaviorJuly 11, 2025 -
Savings Associated With Bundled Payments for Outpatient Spine Surgery Among Medicare Beneficiaries
JAMA Health ForumJuly 11, 2025 -
The Corporatization of U.S. Health Care — A New Perspective Series
The New England Journal of MedicineJuly 2, 2025 -
Association of Stratified Benchmarks With Financial Penalties in the ESRD Treatment Choices Model
JAMAMay 7, 2025 -
Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan
JCO Oncology PracticeApril 25, 2025 -
Change in Default Prescription Length and Statin Prescribing Behavior
JAMA Internal MedicineApril 7, 2025 -
Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation
JAMA CardiologyMarch 26, 2025 -
The effect of a social network-based intervention on adherence to HIV pre-exposure prophylaxis and HIV viral suppression among Kenyan fishermen
AIDSFebruary 13, 2025